Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2004BloodOpen Access

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDavid J. StrausMemorial Sloan Kettering Cancer CenterCPCarol S. PortlockMemorial Sloan Kettering Cancer CenterJQJing QinDalian University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Straus et al. (2004) studied this question.

synapsesocial.com/papers/6a72025622b3175134db6cc9https://doi.org/10.1182/blood-2004-04-1311
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of Common Germinal-Center B-Cell Precursors in Two Patients with Both Hodgkin's Disease and Non-Hodgkin's Lymphoma1999 · 262 citations
  2. 2Nonparametric Estimation from Incomplete Observations1958 · 39,549 citations
  3. 3Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.1991 · 169 citations